#USA #New York #Securities Fraud #Berger Montague #LifeMD

Class Action Lawsuit Against LifeMD, Inc.

A significant class action lawsuit has been initiated against LifeMD, Inc. (NASDAQ: LFMD), a company known for its virtual medical services and prescription delivery, which is headquartered in New York City. The lawsuit, announced by the national law firm Berger Montague, is reflective of the growing scrutiny on publicly traded companies regarding their financial disclosures and operational practices, particularly in light of the rapid adoption of telehealth services.

The allegations in this lawsuit pertain specifically to the activities of LifeMD during a defined period from May 7, 2025, to August 5, 2025, referred to as the ‘Class Period’. During this timeframe, investors who purchased shares of LifeMD may have been misled concerning the company's financial health and market position. The firm asserts that the company overstated its competitive standing within the industry and issued optimistic financial projections for 2025 that failed to align with actual market realities.

According to the complaints, LifeMD did not adequately disclose rising customer acquisition costs that stemmed from regulatory changes and increased market competition, particularly relating to offerings like its RexMD platform. Moreover, the lawsuit highlights that LifeMD had been promoting prescription medications intended for obesity management, such as Wegovy and Zepbound, without clearly communicating the associated costs to stakeholders, which ultimately influenced investor decisions based on incomplete information.

The ramifications of these alleged misstatements were significant, as the true nature of LifeMD’s market challenges became apparent, leading to considerable financial losses for investors. The law firm has advised potential investors who bought shares during the Class Period to consider becoming lead plaintiffs in the lawsuit. The deadline for such applications is set for October 27, 2025.

In their communication, Berger Montague has outlined the rights of investors and encourages them to contact their office for more details regarding the class action. Individuals seeking more information can reach out directly to Andrew Abramowitz, Senior Counsel at Berger Montague, via his provided contact details.

About Berger Montague

Berger Montague is a prominent name in the realm of securities litigation, having represented both individual and institutional investors for over five decades. The firm has a history of taking impactful legal actions against corporations in order to protect the rights of aggrieved investors. With multiple offices across the U.S. and Toronto, Berger Montague has established a reputation for its dedication to upholding investor rights and addressing corporate malfeasance.

In summary, the onset of this lawsuit underscores the critical importance of transparency and accountability in publicly traded companies, particularly within the evolving landscape of the healthcare sector. As telehealth continues to transform the industry, companies like LifeMD must navigate the expectations of investors while maintaining ethical disclosure practices. Investors who feel they may have been misled are urged to stay informed and consider their options carefully as the legal proceedings unfold.